Self-reported long COVID symptoms not identified in diagnostic tests

FHS
July 12, 2023
8:45 am

Researchers describe chronic symptoms related to physical or mental functioning following SARS-CoV-2 infection.

Roche terminates a Phase 3 Spark gene therapy in hemophilia A

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 17, 2024

Psyence Group’s NASDAQ-Listed Associate, Psyence Biomedical, names Albert P. Garcia-Romeu, Ph.D. as Chair of its Newly Created Scientific Advisory Board | Psychedelic Invest

TORONTO, March 10, 2025 (GLOBE NEWSWIRE) — Psyence Group Inc (“Psyence Group” or the “Company“) (CSE: PSYG) is pleased that its NASDAQ-listed associate, Psyence Biomedical

March 11, 2025

After Last Week’s FDA Decision, Everyone’s Talking About What’s Next | Psychedelic Invest

After last week’s rejection of MDMA, everyone has been conjecturing about the future of psychedelics as medicine. Questions surrounding all the delays and need for

August 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.